Quest Diagnostics Incorporated · NYSE:DGX
T. Rowe Price Associates Inc's stake in Quest Diagnostics Incorporated fell to 4.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
T. Rowe Price Associates Inc's stake in Quest Diagnostics Incorporated fell to 4.90%, 5,428,244 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 5,428,244
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 4.90% | 5,428,244 |
Source
Related
- Quest Diagnostics Incorporated
- T. Rowe Price Associates Inc
- Quest Diagnostics Incorporated shareholders
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2025
- Schedule 13G · T. Rowe Price Associates Inc · May 14, 2025
- Form 4 · Carter Robert B · Oct 23, 2026
- Form 4 · Samad Sam · Oct 23, 2026
- Form 4 · Gregg Vicky B · Oct 23, 2026
- Form 4 · Kuppusamy Karthik · Oct 23, 2026
- Form 4 · Lassiter Wright III · Oct 23, 2026